نتائج البحث - "Aimee E. Houlton"

1

Supplemental Table 3 from Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30cac8136a16ee1bad22e1c2d07a962d
https://doi.org/10.1158/1078-0432.22468974.v1

View record in OpenAIRE

2

Supplemental Table 1 from Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2349da5f2731fe9b5293126d52cd1ddb
https://doi.org/10.1158/1078-0432.22468977.v1

View record in OpenAIRE

3

Supplementary Data from Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4008f6bb20cdb6eb9a1403c23f11f16
https://doi.org/10.1158/1078-0432.22468971.v1

View record in OpenAIRE

4

Data from Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c0327fb5df6da2c1e7558e937576087
https://doi.org/10.1158/1078-0432.c.6527109

View record in OpenAIRE

5

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

المصدر: Craddock, C, Houlton, A E, Quek, L S, Ferguson, P, Gbandi, E, Roberts, C, Metzner, M, Garcia-Martin, N, Kennedy, A, Hamblin, A, Raghavan, M, Nagra, S, Dudley, L, Wheatley, K, McMullin, M, Pillai, S P, kelly, R J, Siddique, S, Dennis, M, Cavenagh, J D & Vyas, P 2017, ' Outcome of azacitidine therapy in acute myeloid leukaemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature ', Clinical Cancer Research . https://doi.org/10.1158/1078-0432.CCR-17-1423

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Myeloid, Azacitidine, Hydroxamic Acids, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Immunophenotyping, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Cyclin-Dependent Kinase Inhibitor p18, Humans, Progenitor cell, neoplasms, Vorinostat, Cyclin-Dependent Kinase Inhibitor p16, Aged, business.industry, Cancer, Myeloid leukemia, Middle Aged, medicine.disease, Combined Modality Therapy, Isocitrate Dehydrogenase, Histone Deacetylase Inhibitors, Leukemia, Myeloid, Acute, Leukemia, Treatment Outcome, Editorial, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Mutation, Immunology, Female, Tumor Suppressor Protein p53, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26326dd64b25e6545090d1d151ab6d82
https://doi.org/10.1158/1078-0432.ccr-17-1423

View record in OpenAIRE

6

A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL

المصدر: HEMATOLOGICAL ONCOLOGY

مصطلحات موضوعية: Male, Cancer Research, Gastrointestinal Diseases, Phases of clinical research, Kaplan-Meier Estimate, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Molecular Targeted Therapy, Aged, 80 and over, Hematology, General Medicine, Middle Aged, Progression-Free Survival, Neoplasm Proteins, Oncology, 030220 oncology & carcinogenesis, Benzamides, Neoplastic Stem Cells, Vomiting, Female, Rituximab, Lymphoma, Large B-Cell, Diffuse, medicine.symptom, medicine.drug, Adult, medicine.medical_specialty, Nausea, Morpholines, B-Lymphocyte Subsets, Antineoplastic Agents, Mechanistic Target of Rapamycin Complex 2, Mechanistic Target of Rapamycin Complex 1, 03 medical and health sciences, Refractory, Internal medicine, medicine, Mucositis, Humans, Adverse effect, Protein Kinase Inhibitors, Aged, Salvage Therapy, business.industry, medicine.disease, Transplantation, Pyrimidines, Drug Resistance, Neoplasm, business, 030215 immunology

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::342a9bcaf1271dcb55a698a64675561f

View record in OpenAIRE

7

PEPtalk2:results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer

المؤلفون: Mary Ramsay, Soonie R. Patel, Mark Jit, Roderick Skinner, Catherine O’Sullivan, Jessica Bate, Neil Ransinghe, Judith Breuer, Paul T. Heath, Juliet C. Gray, Guy Makin, Julia C. Chisholm, Sophie Hambleton, Stephen Lowis, Aimee E Houlton, Stephen Baker, Robert J. Phillips, Keith Wheatley

المصدر: Bate, J, Baker, S, Breuer, J, Chisholm, J C, Gray, J, Hambleton, S, Houlton, A, Jit, M, Lowis, S, Makin, G, O'Sullivan, C, Patel, S R, Phillips, R, Ransinghe, N, Ramsay, M E, Skinner, R, Wheatley, K & Heath, P T 2019, ' PEPtalk2 : results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer ', Archives of Disease in Childhood, vol. 104, no. 1, pp. 25-29 . https://doi.org/10.1136/archdischild-2017-314212

مصطلحات موضوعية: Male, Pediatrics, medicine.medical_specialty, Herpesvirus 3, Human, Adolescent, viruses, Psychological intervention, Acyclovir, Pilot Projects, medicine.disease_cause, Antiviral Agents, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, 030225 pediatrics, Neoplasms, medicine, Humans, Aciclovir, Child, Chickenpox, Manchester Cancer Research Centre, business.industry, Incidence (epidemiology), Immune Sera, ResearchInstitutes_Networks_Beacons/mcrc, Varicella zoster virus, Immunization, Passive, Cancer, virus diseases, medicine.disease, Treatment Outcome, England, Child, Preschool, Pediatrics, Perinatology and Child Health, Female, business, Serostatus, Post-Exposure Prophylaxis, medicine.drug